Premium
Study challenges concerns about risk of antipsychotic use during pregnancy
Publication year - 2016
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30106
Subject(s) - pregnancy , medicine , antipsychotic , first trimester , psychiatry , schizophrenia (object oriented programming) , obstetrics , antipsychotic drug , fetus , genetics , biology
Use of a second‐generation antipsychotic during the first trimester of pregnancy did not significantly increase the risk of major malformations in infants, a study that analyzed results from 303 women has concluded. These findings challenge the common practice of discontinuing maintenance treatment for psychotic disorders during pregnancy, study authors stated. The study was published online Oct. 6, 2015, in the American Journal of Psychiatry .